ArticleCPT: pharmacometrics & systems pharmacology2021

PBPK modeling to predict drug-drug interactions of ivosidenib as a perpetrator in cancer patients and qualification of the Simcyp platform for CYP3A4 induction.

Jayaprakasam Bolleddula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.